After ‘Puzzling’ Results For Antibody Drug, AC Immune’s Alzheimer’s Vaccine Shows Early Promise

A Blip Or A Breakthrough In Tau?

Another hard-to-explain result in Alzheimer’s, with AC Immune claiming the first ever validation of anti-tau therapy, but others are more circumspect.

AC Immune
AC Immune has Alzheimers's collaborations in anti-tau and beta-amyloid modalities with companies such as Lilly, J&J and Roche. • Source: Alamy

More from Clinical Trials

More from R&D